Key result
The authors advocate renaming 'degenerative' aortic stenosis to fibrocalcific or sclerocalcific aortic valve disease to better reflect the active biological mechanisms of valve hardening.
The authors advocate for renaming 'degenerative' aortic stenosis to 'fibrocalcific or sclerocalcific aortic valve disease' to better reflect the active biological mechanisms involved.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Aïkawa et al. (2017) conducted an editorial in Nonrheumatic aortic stenosis. The authors advocate renaming 'degenerative' aortic stenosis to fibrocalcific or sclerocalcific aortic valve disease to better reflect the active biological mechanisms of valve hardening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: